Heart Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Heart Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 1 (2005), Issue 3 (March)

1. Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipient.
   J Heart Lung Transplant, 24(3): 355-8. [Abstract] [Full-text]
2. Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation.
   J Heart Lung Transplant, 24(3): 347-9. [Abstract] [Full-text]
3. Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone.
   J Heart Lung Transplant, 24(3): 343-6. [Abstract] [Full-text]
4. Successful transplantation of an older donor heart with documented myocardial bridging: a case report.
   J Heart Lung Transplant, 24(3): 340-2. [Abstract] [Full-text]
5. Graft coronary artery disease in murine cardiac allografts: proposal to meet the need for standardized assessment.
   J Heart Lung Transplant, 24(3): 316-22. [Abstract] [Full-text]
6. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
   J Heart Lung Transplant, 24(3): 296-302. [Abstract] [Full-text]
7. Time course of physical reconditioning during exercise rehabilitation late after heart transplantation.
   J Heart Lung Transplant, 24(3): 270-4. [Abstract] [Full-text]
8. The case for selective re-issuance of medical certificates to allow pilots who have received a heart transplant to resume flying.
   J Heart Lung Transplant, 24(3): 259-69. [Abstract] [Full-text]
9. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
   J Heart Lung Transplant, 24(3): 251-8. [Abstract] [Full-text]
10. Expression of the FAST-1 transcription factor in coronary artery transplant vasculopathy and activated vascular smooth muscle cells.
    J Heart Lung Transplant, 24(3): 246-50. [Abstract] [Full-text]
11. Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response.
    Eur J Immunol, 35(3): 843-51. [Abstract] [Full-text]
12. Thoracic organ transplantation in the United States, 1994-2003.
    Am J Transplant, 5(4): 934-49. [Abstract] [Full-text]
13. First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation.
    Am J Transplant, 5(4): 827-31. [Abstract] [Full-text]
14. Preferential depletion of blood myeloid dendritic cells during acute cardiac allograft rejection under controlled immunosuppression.
    Am J Transplant, 5(4): 810-20. [Abstract] [Full-text]
15. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients.
    Am J Transplant, 5(4): 720-8. [Abstract] [Full-text]
16. Personality characteristics among cardiothoracic transplant recipients.
    Gen Hosp Psychiatry, 27(2): 113-8. [Abstract] [Full-text]
17. Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers.
    J Clin Periodontol, 32(3): 273-9. [Abstract] [Full-text]
18. Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna.
    J Heart Lung Transplant, 24(4): S206-9; discussion S210-1. [Abstract] [Full-text]
19. Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin.
    J Heart Lung Transplant, 24(4): S201-5; discussion S210-1. [Abstract] [Full-text]
20. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference.
    J Heart Lung Transplant, 24(4): S196-200; discussion S210-1. [Abstract] [Full-text]
21. Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.
    J Heart Lung Transplant, 24(4): S191-5; discussion S210-1. [Abstract] [Full-text]
22. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
    J Heart Lung Transplant, 24(4): S185-90; discussion S210-1. [Abstract] [Full-text]
23. A comparative study of resource use and costs of renal, liver and heart transplantation.
    Transpl Int, 18(4): 437-43. [Abstract] [Full-text]
24. Transplantation of organs is transplantations of donor DNA: fate of DNA disseminated in recipient.
    Transpl Int, 18(4): 412-8. [Abstract] [Full-text]
25. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
    Transpl Int, 18(4): 390-5. [Abstract] [Full-text]
26. Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients.
    Am J Cardiol, 95(7): 909-11. [Abstract] [Full-text]
27. Cardiothoracic surgery after heart and heart-lung transplantation.
    Thorac Cardiovasc Surg, 53(2): 85-92. [Abstract] [Full-text]
28. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation.
    Eur J Cardiothorac Surg, 27(4): 554-60. [Abstract] [Full-text]
29. The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options.
    Pediatr Transplant, 9(2): 208-14. [Abstract] [Full-text]
30. Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population.
    Pediatr Transplant, 9(2): 183-6. [Abstract] [Full-text]
31. Beyond the first year after pediatric heart or heart-lung transplantation: Changes in cognitive function and behaviour.
    Pediatr Transplant, 9(2): 170-7. [Abstract] [Full-text]
32. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Scand J Immunol, 61(3): 266-73. [Abstract] [Full-text]
33. Graft ischemic time and outcome of lung transplantation: a multicenter analysis.
    Am J Respir Crit Care Med, 171(7): 786-91. [Abstract] [Full-text]
34. Functional heme oxygenase-1 promoter polymorphism in relation to heart failure and cardiac transplantation.
    J Heart Lung Transplant, 24(4): 493-7. [Abstract] [Full-text]
35. Cardiac transplantation in patients with iron overload cardiomyopathy.
    J Heart Lung Transplant, 24(4): 486-8. [Abstract] [Full-text]
36. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    J Heart Lung Transplant, 24(4): 446-53. [Abstract] [Full-text]
37. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
    J Heart Lung Transplant, 24(4): 439-45. [Abstract] [Full-text]
38. Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy.
    J Heart Lung Transplant, 24(4): 433-8. [Abstract] [Full-text]
39. Brain natriuretic peptide levels do not correlate with acute cellular rejection in De Novo orthotopic heart transplant recipients.
    J Heart Lung Transplant, 24(4): 416-20. [Abstract] [Full-text]
40. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
    J Heart Lung Transplant, 24(4): 411-5. [Abstract] [Full-text]
41. Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression.
    J Heart Lung Transplant, 24(4): 406-10. [Abstract] [Full-text]
42. Early mortality after cardiac transplantation: should we do better?
    J Heart Lung Transplant, 24(4): 401-5. [Abstract] [Full-text]
43. To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
    J Heart Lung Transplant, 24(4): 392-400. [Abstract] [Full-text]
44. Na+/H+ exchange inhibition and antioxidants lack additive protective effects after reperfusion injury in the working heterotopic rat heart isograft.
    J Heart Lung Transplant, 24(4): 386-91. [Abstract] [Full-text]

© 2005-2008 Heart Transplant Research Today. All Rights Reserved.